BLK degrader 1

CAS No. 3049215-64-4

BLK degrader 1( —— )

Catalog No. M36930 CAS No. 3049215-64-4

BLK degrader 1 is a selective B lymphoid tyrosine kinase (BLK) degrader with anticancer activity and can be used for cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 316 In Stock
10MG 511 In Stock
25MG 1017 In Stock
50MG 1600 In Stock
100MG 2567 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BLK degrader 1
  • Note
    Research use only, not for human use.
  • Brief Description
    BLK degrader 1 is a selective B lymphoid tyrosine kinase (BLK) degrader with anticancer activity and can be used for cancer research.
  • Description
    BLK degrader 1 is a selective B lymphoid tyrosine kinase (BLK) degrader with anticancer activity and can be used for cancer research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    BTK
  • Recptor
    BTK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3049215-64-4
  • Formula Weight
    582.58
  • Molecular Formula
    C32H25F3N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC1=CC=CC(NC2=NC=C(NC(C3=CC(NC(C4=CC=C(C5=CC=CC(C(F)(F)F)=C5)C=C4)=O)=CC=C3C)=O)C=N2)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tilfrinib

    Tilfrinib is an effective and selective inhibitor of breast tumor kinase (IC50: 3.15 nM), which displays anti-proliferative activity.

  • Evobrutinib

    A potent, highly selective BTK inhibitor for the treatment of various autoimmune disorders.Rheumatoid ArthritisPhase 2 Clinical

  • BTK-IN-23

    BTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM.